Allstate Investment Management’s Colgate-Palmolive CL Stock Holding History

Allstate Investment Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.85M	Buy	+23,543	New	+$1.77M	0.06%	205

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Allstate Investment Management's CL Position: Q4 2022 in Review

Allstate Investment Management opened a new position in Colgate-Palmolive (CL) in Q4 2022: 23,543 shares worth $1.85M. The stake represents 0.06% of the portfolio and ranks #205 among its holdings.

1,697 funds tracked by Wall St. Rank hold CL as of Q4 2022.

Allstate Investment Management held 23,543 shares of Colgate-Palmolive worth $1.85M as of Q4 2022.
Colgate-Palmolive was a new Allstate Investment Management position in Q4 2022.
Colgate-Palmolive made up 0.06% of Allstate Investment Management's portfolio in Q4 2022, its #205 holding.
1,697 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.